Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of non-small cell lung cancer

Clinical Cancer Research

Volumn 16, Issue 13, 2010, Pages 3452-3462

  Farlow, Erin C ^a   Patel, Kalpa ^a   Basu, Sanjib ^a   Lee, Bao Shiang ^b   Kim, Anthony W ^a,c   Coon, John S ^a   Faber, L Penfield ^a   Bonomi, Philip ^a   Liptay, Michael J ^a   Borgia, Jeffrey A ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BLOOD EXAMINATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMMUNOASSAY; LUNG ADENOCARCINOMA; LUNG NODULE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ADENOCARCINOMA; ALGORITHMS; ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; AUTOANTIBODIES; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; EARLY DETECTION OF CANCER; HEMATOLOGIC TESTS; HUMANS; LUNG NEOPLASMS; PROTEIN ARRAY ANALYSIS; PROTEOMICS;

EID: 77954237777     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-3192     Document Type: Article

References (46)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-49.
2. Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010;116:544-73.
3. Lam WK, Watkins DN. Lung cancer: future directions. Respirology 2007;12:471-7.
4. Spiro SG, Silvestri GA. One hundred years of lung cancer. Am J Respir Crit Care Med 2005;172:523-9.
5. Brower V. Biomarker studies abound for early detection of lung cancer. J Natl Cancer Inst 2009;101:11-3.
6. Bach PB, Kelley MJ, Tate RC, McCrory DC. Screening for lung cancer: a review of the current literature. Chest 2003;123:72-82S.
7. Flehinger BJ, Kimmel M, Polyak T, Melamed MR. Screening for lung cancer. The Mayo Lung Project revisited. Cancer 1993;72:1573-80.
8. Patz EF, Jr., Goodman PC, Bepler G. Screening for lung cancer. N Engl J Med 2000;343:1627-33.
9. Henschke CI, Yankelevitz DF, Libby DM, et al. Early lung cancer action project: annual screening using single-slice helical CT. Ann N Y Acad Sci 2001;952:124-34.
10. Brenner DJ, Hall EJ. Computed tomography-an increasing source of radiation exposure. N Engl J Med 2007;357:2277-84.
11. Sone S, Li F, Yang ZG, et al. Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. Br J Cancer 2001;84:25-32.
12. Borgia JA, Basu S, Faber LP, et al. Establishment of a multianalyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer. J Thorac Oncol 2009;4:338-47.
13. Chapman CJ, Murray A, McElveen JE, et al. Autoantibodies in lung cancer: possibilities for early detection and subsequent cure. Thorax 2008;63:228-33.
14. Gnjatic S, Old LJ, Chen YT. Autoantibodies against cancer antigens. Methods Mol Biol 2009;520:11-9.
15. Tureci O, Mack U, Luxemburger U, et al. Humoral immune responses of lung cancer patients against tumor antigen NY-ESO-1. Cancer Lett 2006;236:64-71.
16. Caron M, Choquet-Kastylevsky G, Joubert-Caron R. Cancer immunomicsusing autoantibody signatures for biomarker discovery. Mol Cell Proteomics 2007;6:1115-22.
17. Gorlova OY, Kimmel M, Henschke C. Modeling of long-term screening for lung carcinoma. Cancer 2001;92:1531-40.
18. Lubin R, Schlichtholz B, Teillaud JL, Garay E, Bussel A, Wild CP. p53 antibodies in patients with various types of cancer: assay, identification, and characterization. Clin Cancer Res 1995;1:1463-9. (Pubitemid 26028081)
19. Mack U, Ukena D, Montenarh M, Sybrecht GW. Serum anti-p53 antibodies in patients with lung cancer. Oncol Rep 2000;7:669-74.
20. Zalcman G, Schlichtholz B, Tredaniel J, et al. Monitoring of p53 autoantibodies in lung cancer during therapy: relationship to response to treatment. Clin Cancer Res 1998;4:1359-66.
21. Zhu CQ, Shih W, Ling CH, Tsao MS. Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation. J Clin Pathol 2006;59:790-800.
22. Chang JW, Lee SH, Jeong JY, et al. Peroxiredoxin-I is an autoimmunogenic tumor antigen in non-small cell lung cancer. FEBS Lett 2005; 579:2873-7.
23. Nakanishi T, Takeuchi T, Ueda K, Murao H, Shimizu A. Detection of eight antibodies in cancer patients' sera against proteins derived from the adenocarcinoma A549 cell line using proteomics-based analysis. J Chromatogr B Analyt Technol Biomed Life Sci 2006;838:15-20.
24. Bazhin AV, Savchenko MS, Shifrina ON, et al. Recoverin as a paraneoplastic antigen in lung cancer: the occurrence of anti-recoverin autoantibodies in sera and recoverin in tumors. Lung Cancer 2004;44:193-8.
25. Yagihashi A, Asanuma K, Kobayashi D, et al. Detection of autoantibodies to livin and survivin in Sera from lung cancer patients. Lung Cancer 2005;48:217-21.
26. Yamamoto A, Shimizu E, Ogura T, Sone S. Detection of autoantibodies against L-myc oncogene products in sera from lung cancer patients. Int J Cancer 1996;69:283-9.
27. Brichory FM, Misek DE, Yim AM, et al. An immune response manifestedby the common occurrence of annexins I and II auto antibodies and high circulating levels of IL-6 in lung cancer. Proc Natl Acad Sci U S A 2001;98:9824-9.
28. Chen G, Wang X, Yu J, et al. Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma. Cancer Res 2007;67:3461-7.
29. Madin K, Sawasaki T, Ogasawara T, Endo Y. A highly efficient and robust cell-free protein synthesis system prepared from wheat embryos: plants apparently contain a suicide system directed at ribosomes. Proc Natl Acad Sci U S A 2000;97:559-64.
30. Sawasaki T, Hasegawa Y, Tsuchimochi M, et al. A bilayer cell-free protein synthesis system for high-throughput screening of gene products. FEBS Lett 2002;514:102-5. (Pubitemid 34251251)
31. Breiman L. Random Forests. Machine Learning 2001;45:5-32.
32. Brieman L, Friedman J, Olshen R, Stone C. Classification and Regression Trees. Wadsworth Co; 1983.
33. Team RDC. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2007.
34. Brichory F, Beer D, Le Naour F, Giordano T, Hanash S. Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer. Cancer Res 2001;61:7908-12.
35. He P, Naka T, Serada S, et al. Proteomics-based identification of α-enolase as a tumor antigen in non-small lung cancer. Cancer Sci 2007;98:1234-40.
36. Nagashio R, Sato Y, Jiang SX, et al. Detection of tumor-specific auto antibodies in sera of patients with lung cancer. Lung Cancer 2008;62:364-73.
37. Qiu J, Madoz-Gurpide J, Misek DE, et al. Development of natural protein microarrays for diagnosing cancer based on an antibody response to tumor antigens. J Proteome Res 2004;3:261-7.
38. Zalcman G, Tredaniel J, Schlichtholz B, et al. Prognostic significance of serum p53 antibodies in patients with limited-stage small cell lung cancer. Int J Cancer 2000;89:81-6.
39. Zhong L, Coe SP, Stromberg AJ. Profiling tumor-associated antibodies for early detection of non-small cell lung cancer. J Thorac Oncol 2006;1:513-9.
40. Watanabe F, Takao M, Inoue K, et al. Immunohistochemical diagnosis of methylthioadenosine phosphorylase (MTAP) deficiencyin nonsmall cell lung carcinoma. Lung Cancer 2009;63:39-44.
41. Lee HA, Kwon B, Hur GY. Isotype and IgG subclass distribution ofautoantibody response to α-enolase protein in adult patients withsevere asthma. Yonsei Med J 2008;49:923-30.
42. Leidinger P, Keller A, Heisel S, et al. Novel autoantigens immunogenic in COPD patients. Respir Res 2009;10:20.
43. Lynch DA. Lung disease related to collagen vascular disease. J Thorac Imaging 2009;24:299-309.
44. Schwartz-Albiez R, Monteiro RC, Rodriguez M, Binder CJ, Shoenfeld Y. Natural antibodies, intravenous immunoglobulin and their role in autoimmunity, cancer and inflammation. Clin Exp Immunol 2009;158 Suppl 1:43-50.
45. Yang M, Wu T, Cheng L, Wang F, Wei Q, Tanguay RM. Plasma antibodiesagainst heat shock protein 70 correlate with the incidenceand severity of asthma in a Chinese population. Respir Res 2005;6:18.
46. Leidinger P, Keller A, Heisel S, et al. Identification of lung cancer withhigh sensitivity and specificity by blood testing. Respir Res 2010;11:18.